Viewing Study NCT06422481



Ignite Creation Date: 2024-06-16 @ 11:47 AM
Last Modification Date: 2024-10-26 @ 3:30 PM
Study NCT ID: NCT06422481
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-05-21
First Post: 2024-05-06

Brief Title: Echocardiographic Measurement of Myocardial Work
Sponsor: Centre Hospitalier Universitaire de Nice
Organization: Centre Hospitalier Universitaire de Nice

Study Overview

Official Title: Non-invasive Measurement of Myocardial Work Using Transthoracic Echocardiography in Critically Ill Patients the MYOLOAD Study
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: MYOLOAD
Brief Summary: Echocardiography is recommended for the hemodynamic management of patients with shock Recently a new echocardiographic method has been proposed that provides a non-invasive measurement of myocardial work incorporating different components namely total myocardial work GWI constructive myocardial work GCW lost myocardial work GWW and effective myocardial work GWE Echocardiographic measurement of myocardial work takes into account both myocardial deformation and left ventricular afterload estimated by measuring systolic blood pressure and unlike the measurement of left ventricular ejection fraction and global longitudinal strain could be less dependent on cardiac load conditions particularly left ventricular afterload To date non-invasive measurement of myocardial work has never been validated in critically ill patients and no study has assessed the effects of different therapies fluids administration administration of norepinephrine on the different components of myocardial work in patients admitted to intensive care unit
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None